Our orders are delivered strictly on time without delay
Following the guidelines of the United States Preventive Service Taskforce (USPSTF), discuss and describe the screening recommendations for the following:
• Cervical cancer
• Breast cancer
• Osteoporosis
• Colorectal cancer
• Lung cancer
• Ovarian cancer
• Intimate partner violence (IPV).
The United States Preventive Services Task Force (USPSTF) provides evidence-based recommendations for clinical preventive services, assigning a letter grade (A, B, C, D, or I) to reflect the strength of the evidence and the balance of benefits and harms.
Here are the current USPSTF screening recommendations for the requested conditions:
| Condition | Target Population | Screening Method | Recommendation Grade |
|---|---|---|---|
| Cervical Cancer | Women aged 21 to 65 | Aged 21–29: Pap test every 3 years. Aged 30–65: Screening every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or co-testing (hrHPV and Pap test), or Pap test alone every 3 years. | A |
| Breast Cancer | Women aged 40 to 74 | Mammography (digital or film). | B (Ages 40-74) |
| Osteoporosis | Women aged 65 and older. Younger women postmenopausal who are at increased risk (based on risk factor assessment). | Dual-Energy X-ray Absorptiometry (DXA) of the hip and lumbar spine. |
The USPSTF gives an A grade to screening for cervical cancer in women aged 21 to 65. The recommendation specifically allows for flexibility after age 30, recognizing the high effectiveness of hrHPV testing in preventing cancer. Screening is not recommended for women under 21, regardless of sexual history, as treatment of common, temporary HPV infections in this group often causes more harm than benefit (overtreatment).
The USPSTF recommends screening for women aged $\text{40}$ to $\text{74}$ with an A grade for women $\text{50}$ to $\text{74}$, but a B grade for women $\text{40}$ to $\text{49}$. This reflects a favorable but smaller net benefit for younger women, advising a clinical discussion to weigh individual risks and preferences. Screening is performed via mammography every $\text{1}$ to $\text{2}$ years.
The USPSTF gives a B grade for screening women aged 65 and older with DXA to prevent osteoporotic fractures. For postmenopausal women younger than 65, screening is recommended only if they are at increased risk of osteoporosis as determined by a risk assessment instrument. There is insufficient evidence ($\text{I}$ grade) to recommend for or against routine screening in men.
Screening for colorectal cancer has an A grade for adults aged $\text{45}$ to $\text{75}$. The USPSTF emphasizes that the greatest benefit is achieved when patients are screened using one of the many recommended effective strategies. The choice of strategy (e.g., FIT, colonoscopy, or CT colonography) should be individualized based on patient preference and resource availability.